Buscar resultados de ensayos clínicos
Peripheral T-cell Lymphoma - 26 Studies Found
Estado | Estudiar |
Completed |
Nombre del estudio: A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea Condición: Peripheral T-cell Lymphoma Fecha: 2012-09-14 Intervenciones:
|
Active, not recruiting |
Nombre del estudio: Phase II Study of Gemcitabine+Romidepsin in the Relapsed/Refractory Peripheral T-cell Lymphoma Patients Condición: Peripheral T-cell Lymphoma Fecha: 2013-03-28 Intervenciones: Drug: Romidepsin, Gemcitabine Romidepsin 12 mg/m2 d.1,8, 15 for 6 cycles + Gemcitabine 800 mg/m2 d.1, 15 |
Completed |
Nombre del estudio: Safety Study to Evaluate Monoclonal Antibody KW-0761 in Subjects With Peripheral T-cell Lymphoma Condición: Peripheral T-Cell Lymphoma Fecha: 2009-04-27 Intervenciones: Biological: KW-0761 The starting dose will be 0.1 mg/kg administered i.v. once every week for four weeks |
Completed |
Nombre del estudio: A Study of Escalating Doses of Romidepsin in Association With CHOP in the Treatment of Peripheral T-Cell Lymphomas Condición: Peripheral T Cell Lymphoma Fecha: 2011-01-14 Intervenciones: Drug: Romidepsin and CHOP Romidepsin dose administered IV at day 1 and 8 or at day 1 without day 8 in co |
Recruiting |
Nombre del estudio: Efficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma Condición: Peripheral T-cell Lymphoma Fecha: 2013-01-31 Intervenciones:
|
RECRUITING |
Nombre del estudio: CMOP Regimen and Chidamide in the Treatment of Newly Diagnosed Peripheral T-cell Lymphoma Condición: Fecha: 2024-05-19 Intervenciones: Cyclophosphamide: 750 mg/m2, d1; Mitoxantrone Hydrochloride Liposome: 20 mg/m2, d1; Vincristine: 1.4 g/m2, d1 (maximum dose of 2 mg), o |